PLCγ1 in dopamine neurons critically regulates striatal dopamine release via VMAT2 and synapsin III

참고문헌 (107)

1. Wise, R. A., "Dopamine, learning and motivation", Nat. Rev. Neurosci, 5, pp.483~494 (2004)
2. Klein, M. O., "Dopamine : functions, signaling, and association with neurological diseases", Cell. Mol. Neurobiol, 39, pp.31~59 (2019)
3. Missale, C., "Dopamine receptors : from structure to function", Physiol. Rev, 78, pp.189~225 (1998)
4. Beaulieu, J. M., "The physiology, signaling, and pharmacology of dopamine receptors", Pharmacol. Rev, 63, pp.182~217 (2011)
5. Morelli, M. B. M., "Handbook of Chemical Neuroanatomy Vol. 21. Dopamine" (2005), Elsevier
6. Matsuda, W., "Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum", J. Neurosci, 29, pp.444~453 (2009)
7. Nicola, S. M., "Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens", Annu. Rev. Neurosci, 23, pp.185~215 (2000)
8. Bjorklund, A., "Dopamine neuron systems in the brain : an update", Trends Neurosci, 30, pp.194~202 (2007)
9. Ehringer, H., "Distribution of noradrenaline and dopamine(3-hydroxytyramine)in the human brain and their behavior in diseases of the extrapyramidal system", Klin. Wochenschr, 38, pp.1236~1239 (1960)
10. Lotharius, J., "Pathogenesis of Parkinson’s disease : dopamine, vesicles and alpha-synuclein", Nat. Rev. Neurosci, 3, pp.932~942 (2002)
11. Carlsson, A., "The current status of the dopamine hypothesis of schizophrenia", Neuropsychopharmacology, 1, pp.179~186 (1988)
12. Snyder, S. H., "Drugs, neurotransmitters, and schizophrenia", Science, 184, pp.1243~1253 (1974)
13. Levy, F., "The dopamine theory of attention deficit hyperactivity disorder(ADHD)", Aust. N. Z. J. Psychiatry, 25, pp.277~283 (1991)
14. Dunlop, B. W., "The role of dopamine in the pathophysiology of depression", Arch. Gen. Psychiatry, 64, pp.327~337 (2007)
15. Wise, R. A., "Dopamine and addiction", Annu. Rev. Psychol, 71, pp.79~106 (2020)
16. 서판길, "Multiple roles of phosphoinositide-specific phospholipase C isozymes", BMB reports, 41(6), pp.415~434 (2008), 한국생화학분자생물학회
17. Jang, H. J., "Phospholipase C-gamma1 involved in brain disorders", Adv. Biol. Regul, 53, pp.51~62 (2013)
18. Kadamur, G., "Mammalian phospholipase C", Annu. Rev. Physiol, 75, pp.127~154 (2013)
19. Yang, Y. R., "Primary phospholipase C and brain disorders", Adv. Biol. Regul, 61, pp.80~85 (2016)
20. Kang, D. S., "The function of PLCgamma1 in developing mouse mDA system", Adv. Biol. Regul, 75, pp.100654~ (2020)
21. Ji, Q. S., "Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts", Mol. Biol. Cell, 9, pp.749~757 (1998)
22. Lawson, N. D., "phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development", Genes Dev, 17, pp.1346~1351 (2003)
23. Liao, H. J., "Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice", J. Biol. Chem, 277, pp.9335~9341 (2002)
24. Choi, J. H., "Phospholipase C-gamma1 potentiates integrin-dependent cell spreading and migration through Pyk2", paxillin activation, 2007, pp.19, 1784~1796
25. Wang, X. T., "Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival", J. Biol. Chem, 276, pp.28364~28371 (2001)
26. Yang, Y. R., "Forebrain-specific ablation of phospholipase Cgamma1 causes manic-like behavior", Mol. Psychiatry, 22, pp.1473~1482 (2017)
27. Kang, D. S., "Netrin-1", DCC-mediated PLCgamma1 activation is required for axon guidance and brain structure development, 2018, pp.19, e46250~
28. Kim, H. Y., "Deletion of PLCgamma1 in GABAergic neurons increases seizure susceptibility in aged mice", Sci. Rep, 9, pp.17761~ (2019)
29. Wolf, D. H., "Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration", J. Neurochem, 73, pp.1520~1528 (1999)
30. Wolf, D. H., "Regulation of neuronal PLCγ by chronic morphine", Brain Res, 1156, pp.9~20 (2007)
31. Bolanos, C. A., "Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors", J. Neurosci, 23, pp.7569~7576 (2003)
32. Suh, P. G., "Monoclonal antibodies to three phospholipase C isozymes from bovine brain", J. Biol. Chem, 263, pp.14497~14504 (1988)
33. Bermejo, M. K., "Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient", J. Vis. Exp, 91, pp.e51896~ (2014)
34. Baquet, Z. C., "A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL", 6J mouse, 2009, pp.161, 1082~1090
35. Ip, C. W., "Stereological estimation of dopaminergic neuron number in the mouse substantia nigra using the optical fractionator and standard microscopy equipment", J. Vis. Exp, 127, pp.e56103~ (2017)
36. Kummari, E., "Laser capture microdissection-a demonstration of the isolation of individual dopamine neurons and the entire ventral tegmental area", J. Vis. Exp, 96, pp.e52336~ (2015)
37. Asano, S. M., "Expansion microscopy : protocols for imaging proteins and RNA in cells and tissues", Curr. Protoc. Cell Biol, 80, pp.e56~ (2018)
38. Lee, B. E., "O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease", Brain, 143, pp.3699~3716 (2020)
39. Ventura, A., "Cre-lox-regulated conditional RNA interference from transgenes", Proc. Natl Acad. Sci. USA, 101, pp.10380~10385 (2004)
40. Livak, K. J., "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", Methods, 25, pp.402~408 (2001)
41. Backman, C. M., "Characterization of a mouse strain expressing Cre recombinase from the 3′ untranslated region of the dopamine transporter locus", Genesis, 44, pp.383~390 (2006)
42. Amo, R., "A gradual temporal shift of dopamine responses mirrors the progression of temporal difference error in machine learning", Nat. Neurosci, 25, pp.1082~1092 (2022)
43. Condon, M. D., "Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter", Nat. Commun, 10, pp.4263~ (2019)
44. Stuber, G. D., "Considerations when using cre-driver rodent lines for studying ventral tegmental area circuitry", Neuron, 85, pp.439~445 (2015)
45. Lammel, S., "Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons", Neuron, 85, pp.429~438 (2015)
46. Threlfell, S., "Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons", Neuron, 75, pp.58~64 (2012)
47. Wen, R., "An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion", EMBO J, 23, pp.4007~4017 (2004)
48. Park, H., "Neurotrophin regulation of neural circuit development and function", Nat. Rev. Neurosci, 14, pp.7~23 (2013)
49. Robinson, D. L., "Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo", Clin. Chem, 49, pp.1763~1773 (2003)
50. Venton, B. J., "Fundamentals of fast-scan cyclic voltammetry for dopamine detection", Analyst, 145, pp.1158~1168 (2020)
51. Zhou, F. M., "Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum", Nat. Neurosci, 4, pp.1224~1229 (2001)
52. Brimblecombe, K. R., "Targeted activation of cholinergic interneurons accounts for the modulation of dopamine by striatal nicotinic receptors", eNeuro, 5, pp.ENEURO.0397–17~ (2018)
53. Kim, J. I., "Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons", Science, 350, pp.102~106 (2015)
54. Hage, T. A., "Electrical and Ca(2+)signaling in dendritic spines of substantia nigra dopaminergic neurons", Elife, 5, pp.e13905~ (2016)
55. Watabe-Uchida, M., "Whole-brain mapping of direct inputs to midbrain dopamine neurons", Neuron, 74, pp.858~873 (2012)
56. Pinault, D., "A novel single-cell staining procedure performed in vivo under electrophysiological control : morpho-functional features of juxtacellularly labeled thalamic cells and other central neurons with biocytin or Neurobiotin", J. Neurosci. Methods, 65, pp.113~136 (1996)
57. Grace, A. A., "Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro", J. Neurosci, 9, pp.3463~3481 (1989)
58. Grace, A. A., "Intracellular and extracellular electrophysiology of nigral dopaminergic neurons–1. Identification and characterization", Neuroscience, 10, pp.301~315 (1983)
59. Neuhoff, H., "I(h)channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain", J. Neurosci, 22, pp.1290~1302 (2002)
60. Ford, C. P., "Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location", J. Neurosci, 26, pp.2788~2797 (2006)
61. Luo, S. X., "TGF-beta signaling in dopaminergic neurons regulates dendritic growth, excitatory-inhibitory synaptic balance, and reversal learning", Cell Rep, 17, pp.3233~3245 (2016)
62. Brichta, L., "Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease : an update", Front. Neuroanat, 8, pp.152~ (2014)
63. Roselli, F., "From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases", Neuron, 85, pp.901~910 (2015)
64. Fei, H., "Trafficking of vesicular neurotransmitter transporters", Traffic, 9, pp.1425~1436 (2008)
65. Mulvihill, K. G., "Presynaptic regulation of dopamine release : role of the DAT and VMAT2 transporters", Neurochem. Int, 122, pp.94~105 (2019)
66. Lohr, K. M., "Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo", Proc. Natl Acad. Sci. USA, 111, pp.9977~9982 (2014)
67. Gallagher, B. R., "Expansion microscopy : a powerful nanoscale imaging tool for neuroscientists", Neurobiol. Dis, 154, pp.105362~ (2021)
68. Sneve, M. A., "Towards a comprehensive optical connectome at single synapse resolution via expansion microscopy", Front. Synaptic Neurosci, 13, pp.754814~ (2021)
69. Liu, C., "Dopamine secretion is mediated by sparse active zone-like release sites", Cell, 172, pp.706~718 (2018)
70. Kramer, P. F., "Axonal mechanisms mediating gamma-aminobutyric acid receptor type A(GABA-A)inhibition of striatal dopamine release", Elife, 9, pp.e55729~ (2020)
71. Lopes, E. F., "Inhibition of nigrostriatal dopamine release by striatal GABAA and GABAB receptors", J. Neurosci, 39, pp.1058~1065 (2019)
72. Boccalaro, I. L., "Cell type-specific distribution of GABAA receptor subtypes in the mouse dorsal striatum", J. Comp. Neurol, 527, pp.2030~2046 (2019)
73. Petri, S., "Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra", J. Comp. Neurol, 452, pp.360~366 (2002)
74. Brunig, I., "BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABA(A) receptor surface expression", Eur. J. Neurosci, 13, pp.1320~1328 (2001)
75. Tanaka, T., "Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor(BDNF)in rat hippocampus", J. Neurosci, 17, pp.2959~2966 (1997)
76. Ford, C. P., "The role of D2-autoreceptors in regulating dopamine neuron activity and transmission", Neuroscience, 282, pp.13~22 (2014)
77. Camilli, P. D., "The Synapsins", Annu. Rev. Cell Biol, 6, pp.433~460 (1990)
78. Cesca, F., "The synapsins : key actors of synapse function and plasticity", Prog. Neurobiol, 91, pp.313~348 (2010)
79. 송상호, "Synapsin Isoforms and Synaptic Vesicle Trafficking", Molecules and Cells, 38(11), pp.936~940 (2015), 한국분자세포생물학회
80. Faustini, G., "Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson’s disease-like phenotype", Mol. Ther, 30, pp.1465~1483 (2022)
81. Kile, B. M., "Synapsins differentially control dopamine and serotonin release", J. Neurosci, 30, pp.9762~9770 (2010)
82. Porton, B., "Synapsin III : role in neuronal plasticity and disease", Semin. Cell Dev. Biol, 22, pp.416~424 (2011)
83. Han, S. J., "Synapsin IIb interacts with the C-terminal SH2 and SH3 domains of PLCgamma1 and inhibits its enzymatic activity", Cell Biol. Int, 28, pp.943~948 (2004)
84. Onofri, F., "Specificity of the binding of synapsin I to Src homology 3 domains", J. Biol. Chem, 275, pp.29857~29867 (2000)
85. Martin, T. F., "Role of PI(4, 5)P(2)in vesicle exocytosis and membrane fusion", Subcell. Biochem, 59, pp.111~130 (2012)
86. Koch, M., "Coupling exo-and endocytosis : an essential role for PIP(2)at the synapse", Biochim. Biophys. Acta, 1821, pp.1114~1132 (2012)
87. Numakawa, T., "Brain-derived neurotrophic factor triggers a rapid glutamate release through increase of intracellular Ca(2+)and Na(+)in cultured cerebellar neurons", J. Neurosci. Res, 66, pp.96~108 (2001)
88. Kelm, M. K., "The PLC", IP 3 R, Neuropharmacology, pp.2010, 58[DOI]
89. Hammond, G. R., "Elimination of plasma membrane phosphatidylinositol(4, 5)-bisphosphate is required for exocytosis from mast cells", J. Cell Sci, 119, pp.2084~2094 (2006)
90. Davletov, B. A., "Vesicle exocytosis stimulated by alpha-latrotoxin is mediated by latrophilin and requires both external and stored Ca2", EMBO J, 17, pp.3909~3920 (1998)
91. Rhee, J. S., "Beta phorbol ester-and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs", Cell, 108, pp.121~133 (2002)
92. Bauer, C. S., "Potentiation of exocytosis by phospholipase C-coupled G-protein-coupled receptors requires the priming protein Munc13-1", J. Neurosci, 27, pp.212~219 (2007)
93. Majewski, H., "Protein kinase C : a physiological mediator of enhanced transmitter output", Prog. Neurobiol, 55, pp.463~475 (1998)
94. Turner, K. M., "Protein phosphorylation and the regulation of synaptic membrane traffic", Trends Neurosci, 22, pp.459~464 (1999)
95. Gabriel, L. R., "Dopamine transporter endocytic trafficking in striatal dopaminergic neurons : differential dependence on dynamin and the actin cytoskeleton", J. Neurosci, 33, pp.17836~17846 (2013)
96. He, D., "Anaplastic lymphoma kinase regulates internalization of the dopamine D2 receptor", Mol. Pharmacol, 97, pp.123~131 (2020)
97. Delos Santos, R. C., "Selective regulation of clathrin-mediated epidermal growth factor receptor signaling and endocytosis by phospholipase C and calcium", Mol. Biol. Cell, 28, pp.2802~2818 (2017)
98. Choi, J. H., "Phospholipase C-gamma1 is a guanine nucleotide exchange factor for dynamin-1 and enhances dynamin-1-dependent epidermal growth factor receptor endocytosis", J. Cell Sci, 117, pp.3785~3795 (2004)
99. Birbeck, J. A., "Potentiated striatal dopamine release leads to hyperdopaminergia in female brain-derived neurotrophic factor heterozygous mice", ACS Chem. Neurosci, 5, pp.275~281 (2014)
100. Dluzen, D. E., "Evaluation of nigrostriatal dopaminergic function in adult +", + and +, Exp. Neurol, pp.2001, 170[DOI]
101. Dluzen, D. E., "Alterations in nigrostriatal dopaminergic function within BDNF mutant mice", Exp. Neurol, 160, pp.500~507 (1999)
102. Apawu, A. K., "Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics", ACS Chem. Neurosci, 4, pp.895~904 (2013)
103. Hilfiker, S., "Synapsins as regulators of neurotransmitter release", Philos. Trans. R. Soc. Lond. B Biol. Sci, 354, pp.269~279 (1999)
104. Bogen, I. L., "Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters", J. Neurochem, 96, pp.1458~1466 (2006)
105. Feng, J., "Regulation of neurotransmitter release by synapsin III", J. Neurosci, 22, pp.4372~4380 (2002)
106. Song, S. H., "Synapsin isoforms regulating GABA release from hippocampal interneurons", J. Neurosci, 36, pp.6742~6757 (2016)
107. de Jong, A. P. H., "RIM C(2)B domains target presynaptic active zone functions to PIP(2)-containing membranes", Neuron, 98, pp.335~349 (2018)

관련 논문AI추천